Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

62.35
Delayed Data
As of Feb 12
 +1.83 / +3.02%
Today’s Change
52.01
Today|||52-Week Range
134.26
-16.45%
Year-to-Date

Today’s Trading

Previous close60.52
Today’s open61.44
Day’s range58.86 - 63.01
Volume1,941,486
Average volume (3 months)2,859,535
Market cap$7.0B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+9.20%
Earnings growth (next 5 years)+8.99%
Revenue growth (last year)+31.75%
P/E ratio21.6
Price/Sales2.40
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+1.06+0.94%
RDYDr.Reddy's Laborator...-0.42-0.99%
IDXXIDEXX Laboratories I...+0.58+0.86%
UTHRUnited Therapeutics ...+4.95+4.07%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$1.75
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers